Biolife Solutions (BLFS) Capital Expenditures Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Biolife Solutions | 1.20 Bn | 1.12 Bn | 17.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.28% |
| Dec 31, 2025 | 92.45% |
| Sep 30, 2025 | -70.33% |
| Jun 30, 2025 | 48.06% |
| Mar 31, 2025 | 96.33% |
| Dec 31, 2024 | 53.47% |
| Sep 30, 2024 | 82.10% |
| Jun 30, 2024 | 4.64% |
| Mar 31, 2024 | -30.12% |
| Dec 31, 2023 | 187.44% |
| Sep 30, 2023 | 120.04% |
| Jun 30, 2023 | 98.73% |
| Mar 31, 2023 | 140.44% |
| Dec 31, 2022 | -139.38% |
| Sep 30, 2022 | 183.92% |
| Jun 30, 2022 | 118.32% |
| Mar 31, 2022 | 108.27% |
| Dec 31, 2021 | 259.72% |
| Sep 30, 2021 | -166.86% |
| Jun 30, 2021 | 51.30% |
| Mar 31, 2021 | 25.50% |
| Dec 31, 2020 | -18.27% |
| Sep 30, 2020 | 30.17% |
| Jun 30, 2020 | 51.32% |
| Mar 31, 2020 | -31.95% |
| Sep 30, 2019 | -4.20% |
| Jun 30, 2019 | 22.76% |
| Mar 30, 2019 | 52.72% |
| Dec 31, 2018 | 26.22% |
| Sep 30, 2018 | 25.31% |
| Jun 30, 2018 | -16.10% |
| Mar 30, 2018 | 3.85% |
| Dec 31, 2017 | -28.09% |
| Sep 30, 2017 | -38.33% |
| Jun 30, 2017 | -46.94% |
| Mar 31, 2017 | -4.68% |
| Dec 31, 2016 | -17.99% |
| Sep 30, 2016 | 16.89% |
| Jun 30, 2016 | -76.67% |
| Mar 31, 2016 | 110.17% |
| Dec 31, 2015 | 92.10% |
| Sep 30, 2015 | 66.45% |